Venture Funding Deals, July – August 2016

08 Sep 2016

• By Deanna Kamienski, Beth Allan, Maureen Riordan, Steven Muntner, and Amanda Micklus

Ambrx, Arcus, Cleave Biosciences, InflaRx, MonoSol Rx, Nevakar and Tioma Therapeutics were among firms raising more than $30m in venture funding in July and August. Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive review of emerging biopharmaceutical companies that have received venture funding during the past two months.

Venture Funding Deals, July – August 2016

More from Business

More from Scrip